Health Security (Expansion Program)

Drug-resistant TB is on the rise

Inadequate tools to diagnose, treat and prevent TB are major drivers of the global epidemic.

Strong public health systems reduce vulnerability to infectious diseases.

Burnet’s Health Security Program works to increase the capacities of health systems across the Asia-Pacific region.

Major components of this Program are aimed at improving responses to drug-resistant tuberculosis, strengthening policies and practices to prevent and control antimicrobial resistance, and applying One Health approaches to improve health for humans, animals and the environment.

Through this program Burnet is committing to making a major contribution:

To improve understanding of infectious disease threats and apply new tools to improve health security
To contribute to strengthening core public health system capacities required to prepare for and respond to infectious disease threats in the Asia-Pacific region
To make a major contribution to respond to tuberculosis, especially drug resistant tuberculosis, in the Asia-Pacific region
To increase the capacity of health professionals, researchers, policy makers and the general community in relation to health security, through education and training in Australia, our region and globally.

Download

Program Goals and Objectives (69.3 KB)

Contact Details

Doctor Ben Coghlan

Program Director, Health Security (Expansion Program)

Telephone

+61392822177

Email

ben.coghlan@burnet.edu.au

Projects

ANCP: Prevention and care for drug-resistant TB in Myanmar
Implementation and evaluation of a model of drug-resistant TB care to facilitate scale-up in Myanmar.
Antibody mAbs to destroy infection: engineering the next generation treatments
Applying discoveries from our cancer mAb program to neutralize and destroy pathogens.
APPRISE - Centre for Research Excellence
The Australian Partnership for Preparedness Research on Infectious Diseases Emergencies (APPRISE).
Australia Awards Fellowship: KICK-AMR to Address Antimicrobial Resistance
Strengthening response to antimicrobial resistance and health security in the Pacific.
Building a Centre of Excellence for Research and Training for DR-TB in Daru, Papua New Guinea
Building operational research capacity for TB in PNG through training, mentorship and research.
Building capacity and improving tuberculosis diagnosis in Timor-Leste
This project seeks to improve the diagnosis of people with TB with the use of GeneXpert technology.
Characterisation of retroviruses in bats
This study aims to identify and characterise retroviral sequences found in bat specimens.
Demonstrating the impact of next generation Cepheid tools in TB
GeneXpert Ultra and GeneXpert Omni for the diagnosis of tuberculosis at the microscopy centre level: PNG
Enhanced screening and preventive therapy for TB in Daru, PNG (ESCAPE-TB)
A community-based model for screening and delivering preventive therapy for latent TB in Daru, PNG
Novel reagents for the serological diagnosis of tuberculosis
Using a drop of blood, an innovative diagnostic test may be able to detect if a patient has tuberculosis (TB).
Predicting quality and potency of monoclonal and natural antibodies
Rapid, simple and scalable assays for predicting antibody potency.
Rapid and accurate diagnosis of TB: New trial in PNG
New PNG arm of a randomised control trial to trial new tuberculosis point-of-care technology.
RID-TB Patient Education and Counselling
Reducing the impact of DR-TB through patient-centred education and counselling in Daru, PNG.
RID-TB: Reducing the Impact of Drug-Resistant TB in Western Province, PNG
The project supports an effective provincial program to reduce the impact of TB in Daru.
The production of guidance for the laboratory sector to prepare for emergency situations
A project to produce a global guide to maintain diagnostic capacity in emergency settings.
The Social and Cultural Determinants of TB in Daru [SCuD-TB Daru – Study 1]
A pilot project about people with TB and their contacts: beliefs, access to services and experiences.

Latest News

20 February, 2019

New agreement for PNG research

Burnet Institute is collaborating with Papua New Guinea’s National Department of Health to improve health evidence, services and outcomes in PNG.
23 January, 2019

Forging closer TB ties with PNG

Burnet has been pleased to host Dr Gibson Pawape, the new Senior Specialist Medical Officer at Daru General Hospital, PNG.

Upcoming Events

24 March, 2019

World Tuberculosis (TB) Day

World Tuberculosis Day aims to build public awareness about the global epidemic of tuberculosis and efforts to eliminate the disease.
25 April, 2019

World Malaria Day

Malaria remains endemic in around 100 countries with more than three billion people at risk.

Our mission:

To achieve better health for vulnerable communities in Australia and internationally by accelerating the translation of research, discovery and evidence into sustainable health solutions.

Contact Us

85 Commercial Road, Melbourne
VIC, 3004, Australia

E: reception@burnet.edu.au
T: +61 3 9282 2111

Intranet Site Map Careers

Disclaimer Privacy Policy Complaints Policy

This website was developed with the generous support of a donor.

Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung and Wurundjeri people and we offer our respects to the elders past and present.
We recognise and respect the cultural heritage of this land.

Reduce HIV transmissions in Australia Appeal

Support Our Work

Burnet Institute: Medical Research. Practical Action.

Equity through better health

Health Security (Expansion Program)

Drug-resistant TB is on the rise